368 related articles for article (PubMed ID: 21669931)
1. Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
Siller SS; Broadie K
Dis Model Mech; 2011 Sep; 4(5):673-85. PubMed ID: 21669931
[TBL] [Abstract][Full Text] [Related]
2. GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.
Gatto CL; Pereira D; Broadie K
Neurobiol Dis; 2014 May; 65():142-59. PubMed ID: 24423648
[TBL] [Abstract][Full Text] [Related]
3. In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.
Coffee RL; Williamson AJ; Adkins CM; Gray MC; Page TL; Broadie K
Hum Mol Genet; 2012 Feb; 21(4):900-15. PubMed ID: 22080836
[TBL] [Abstract][Full Text] [Related]
4. Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.
Coffee RL; Tessier CR; Woodruff EA; Broadie K
Dis Model Mech; 2010; 3(7-8):471-85. PubMed ID: 20442204
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.
Siller SS; Broadie K
Neural Plast; 2012; 2012():124548. PubMed ID: 22685676
[TBL] [Abstract][Full Text] [Related]
6. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
Golovin RM; Vest J; Broadie K
J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
[TBL] [Abstract][Full Text] [Related]
7. Neuron class-specific requirements for Fragile X Mental Retardation Protein in critical period development of calcium signaling in learning and memory circuitry.
Doll CA; Broadie K
Neurobiol Dis; 2016 May; 89():76-87. PubMed ID: 26851502
[TBL] [Abstract][Full Text] [Related]
8. Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome.
Russo A; DiAntonio A
Cell Rep; 2019 Sep; 28(10):2581-2593.e5. PubMed ID: 31484070
[TBL] [Abstract][Full Text] [Related]
9. The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons.
Tessier CR; Broadie K
Neurobiol Dis; 2011 Jan; 41(1):147-59. PubMed ID: 20843478
[TBL] [Abstract][Full Text] [Related]
10. Genetic background mutations drive neural circuit hyperconnectivity in a fragile X syndrome model.
Kennedy T; Rinker D; Broadie K
BMC Biol; 2020 Jul; 18(1):94. PubMed ID: 32731855
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate rescues neuronal defects in the Drosophila model of Fragile X Syndrome.
Hutson RL; Thompson RL; Bantel AP; Tessier CR
Life Sci; 2018 Feb; 195():65-70. PubMed ID: 29317220
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor-mediated use-dependent down-regulation of synaptic excitability involves the fragile X mental retardation protein.
Repicky S; Broadie K
J Neurophysiol; 2009 Feb; 101(2):672-87. PubMed ID: 19036865
[TBL] [Abstract][Full Text] [Related]
13. Neuronal activity drives FMRP- and HSPG-dependent matrix metalloproteinase function required for rapid synaptogenesis.
Dear ML; Shilts J; Broadie K
Sci Signal; 2017 Nov; 10(504):. PubMed ID: 29114039
[TBL] [Abstract][Full Text] [Related]
14. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.
Dziembowska M; Pretto DI; Janusz A; Kaczmarek L; Leigh MJ; Gabriel N; Durbin-Johnson B; Hagerman RJ; Tassone F
Am J Med Genet A; 2013 Aug; 161A(8):1897-903. PubMed ID: 23824974
[TBL] [Abstract][Full Text] [Related]
15. Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila.
Friedman SH; Dani N; Rushton E; Broadie K
Dis Model Mech; 2013 Nov; 6(6):1400-13. PubMed ID: 24046358
[TBL] [Abstract][Full Text] [Related]
16. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
17. Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects.
Pepper AS; Beerman RW; Bhogal B; Jongens TA
PLoS One; 2009 Oct; 4(10):e7618. PubMed ID: 19888420
[TBL] [Abstract][Full Text] [Related]
18. Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory.
Doll CA; Broadie K
Development; 2015 Apr; 142(7):1346-56. PubMed ID: 25804740
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
20. Fragile X Mental Retardation Protein positively regulates PKA anchor Rugose and PKA activity to control actin assembly in learning/memory circuitry.
Sears JC; Choi WJ; Broadie K
Neurobiol Dis; 2019 Jul; 127():53-64. PubMed ID: 30771457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
